Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,812 | -99,560 | -115,601 | 27,865 | 8,979 |
| Depreciation Amortization | 20,125 | 74,586 | 59,896 | 38,780 | 19,131 |
| Income taxes - deferred | 1,397 | 20,621 | 17,113 | 15,998 | 3,463 |
| Accounts receivable | 8,559 | -7,748 | 4,903 | 776 | 3,917 |
| Accounts payable and accrued liabilities | 2,464 | 3,084 | 3,409 | 2,772 | -6,976 |
| Other Working Capital | 3,134 | -15,555 | 272 | 1,428 | 4,304 |
| Other Operating Activity | -5,032 | 213,961 | 186,265 | 14,718 | 16,283 |
| Operating Cash Flow | $35,459 | $189,389 | $156,257 | $102,337 | $49,101 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,548 | -10,636 | -8,518 | -4,426 | -2,836 |
| Net Acquisitions | -16,702 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -69,629 | -252,212 | -207,017 | -105,781 | -56,055 |
| Sale Of Investment | 69,250 | 179,572 | 132,627 | 79,462 | 43,361 |
| Investing Cash Flow | $-25,629 | $-83,276 | $-82,908 | $-30,745 | $-15,530 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 287,500 | N/A | 287,500 | N/A |
| Debt Repayment | -2,813 | -210,885 | 79,427 | -205,260 | -2,813 |
| Common Stock Issued | N/A | 2,298 | 1,364 | 1,364 | N/A |
| Common Stock Repurchased | N/A | -25,000 | -25,000 | -25,000 | N/A |
| Other Financing Activity | -181 | -36,550 | -36,473 | -36,441 | -4 |
| Financing Cash Flow | $-2,994 | $17,363 | $19,318 | $22,163 | $-2,817 |
| Beginning Cash Position | 276,774 | 153,298 | 153,298 | 153,298 | 153,298 |
| End Cash Position | 283,610 | 276,774 | 245,965 | 247,053 | 184,052 |
| Net Cash Flow | $6,836 | $123,476 | $92,667 | $93,755 | $30,754 |
| Free Cash Flow | |||||
| Operating Cash Flow | 35,459 | 189,389 | 156,257 | 102,337 | 49,101 |
| Capital Expenditure | -8,548 | -10,636 | -8,518 | -4,426 | -2,836 |
| Free Cash Flow | 26,911 | 178,753 | 147,739 | 97,911 | 46,265 |